home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:Olin Corporation
Stock Symbol:OLN
Market:NYSE
Website:olin.com

Menu

OLN OLN Quote OLN Short OLN News OLN Articles OLN Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

CRON - 420 with CNW - New Study Reports Patients Say Marijuana More Helpful for Musculoskeletal Pain Than Conventional Medications

A recent study highlights that more than 20% of patients visiting orthopedic surgeons for chronic musculoskeletal (MSK) pain have turned to marijuana for relief . Among these individuals, nearly two-thirds found marijuana to be somewhat effective, and more than 90% reported at least slight effec...

RELX - Overweight Recommendation Issued On RELX By Morgan Stanley

2024-07-26 16:17:03 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RELX on July 26, 2024 03:06PM ET. The previous analyst recommendation was Overweight. RELX was trading at $46.6 at issue of the analyst recommendation. Historical Analyst Recommendations...

EVRI - Hold Recommendation Issued On EVRI By Craig-Hallum

2024-07-26 16:16:03 ET Craig-Hallum analyst issues HOLD recommendation for EVRI on July 26, 2024 03:06PM ET. EVRI was trading at $12.915 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Hold recommend...

MMM - 3M (MMM) Q2 2024 Earnings Call Transcript

2024-07-26 16:15:16 ET Image source: The Motley Fool. 3M (NYSE: MMM) Q2 2024 Earnings Call Jul 26, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: 3M (MMM) Q2 2024 Earnings Call Transcript

BTI - Buy Recommendation Issued On BTI By Deutsche Bank

2024-07-26 16:15:01 ET Deutsche Bank analyst issues BUY recommendation for BTI on July 26, 2024 03:22PM ET. The previous analyst recommendation was Buy. BTI was trading at $35.165 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...

ARLP - Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.70 Per Unit; Announces Robinson Retirement from Alliance Board, Vining Election to Alliance Board, and Watson promotion to Senior Vice President

Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announced that the Board of Directors of ARLP's general partner ("Board of Directors") approved a cash distribution to its unitholders for the quarter ended June 30, 2024 (the "2024 Quarter"). ARLP unitholders of record as of the close of ...

BKKT - Bakkt Schedules Conference Call to Discuss Second Quarter 2024 Results

Bakkt Holdings, Inc. (NYSE: BKKT) announced today that it will release its second quarter 2024 earnings on Wednesday, August 14, 2024, before market open. Management will host a conference call at 8:30 a.m. ET on the same day to review the results and answer questions. Attendance information is p...

RUP:CC - Rupert Resources Files Final Short Form Prospectus in Connection With Bought Deal Equity Financing and Provides Clarification With Respect to the Previously Filed "Preliminary Economic Assessment Ikkari and Pahtavaara - Finland"

Final Short Form Prospectus Accessible on SEDAR+ NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. Rupert Resources Ltd. ( TSX:RUP ) (&#x...

RUPRF - Rupert Resources Files Final Short Form Prospectus in Connection With Bought Deal Equity Financing and Provides Clarification With Respect to the Previously Filed "Preliminary Economic Assessment Ikkari and Pahtavaara - Finland"

Final Short Form Prospectus Accessible on SEDAR+ NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. Rupert Resources Ltd. ( TSX:RUP ) (&#x...

CGTX - Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at 8:30am ET on Monday July 29, 2024

PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders will host an investor webcast on Monday, July 29, 2024...

Previous 10 Next 10